To study the possible role of an "increased thrombotic tendency" in the vascular complications of diabetes several tests of haemostatic function were carried out on 91 men and 63 women with diabetes aged 35-54 years and the results compared with findings in 686 men and 393 women of the same age in the Northwick Park Heart Study. Mean values for factors VII and X, fibrinogen, and platelet adhesiveness were higher in the diabetics, but mean fibrinolytic activity and whole blood platelet counts were lower. Antithrombin III values were also higher in the diabetics, which may have constituted a protective response to other changes favouring the onset of vascular disease. Diabetics with retinopathy had higher factor VII and antithrombin III values, and those with proteinuria had higher values for factor VII, fibrinogen, and platelet adhesiveness than those without these complications.
Introduction
The excess cardiovascular morbidity and mortality among diabetics in developed countries have not been fully explained by major risk factors such as hypertension, cigarette smoking, and hypercholesterolaemia.' Increasing attention is being paid to disordered haemostatic mechanisms in the pathogenesis of vascular disease in non-diabetics,2 and such disorders may be of special importance in determining the increased risk of both large-vessel and small-vessel disease in diabetes.3
Evidence of an "increased thrombotic tendency" in diabetes would have aetiological, preventive, and therapeutic implications. Findings in a high-risk group such as diabetics may be relevant not only to diabetes itself but also to the pathogenesis of arterial disease in general. Furthermore In both the diabetic and non-diabetic groups blood was taken without venecompression (unless otherwise unobtainable) between 0700 and 1100. At the time of sampling, the diabetics had been fasting for 12 hours and had not had their morning dose of insulin or oral treatment. Blood samples from the non-diabetics, however., were taken after their usual breakfast. Multiple regression analysis in the NPHS sample showed no association between diet after rising (total energy or proportion of energy derived from carbohydrate, fat, or protein) and any of the haemostatic variables examined, with the exception of an apparent lowering of platelet adhesiveness by about 9(7), /1000 kcal (4 2 MJ). The average breakfast provided about 300 kcal, so that the non-fasting values for platelet adhesiveness in this group may have been about 3",, lower on average than if samples had been taken during fasting. With this possible exception the difference in recent food intake between the two groups seemed unlikely to account for any haemostatic differences observed.
Since age and the duration of diabetes are associated with each other and with the development of arterial disease, retinopathy, and values were also higher in the diabetics, the differences achieving significance for patients with IDD and all diabetics combined.
Fibrinolytic activity was highly significantly less in men and women with NIDD than in non-diabetics. From multiple regression analysis this difference was to only a small extent attributable to the greater obesity of patients with NIDD. Fibrinolytic activity was also less in women with IDD than in non-diabetics.
Platelet adhesiveness was consistently and substantially greater in the diabetics than non-diabetics; platelet count was consistently lower.
Assay of factors II and X in 33 men with IDD and 19 non-diabetic men showed a significantly higher mean factor X value in the diabetics.
Factor II values, however, did not differ significantly (table IVm) . Table V gives the findings for all diabetics according to the presence and absence of retinopathy and proteinuria. Factor VII and antithrombin III values were significantly higher in those with retinopathy than in those without. Factor VII values, fibrinogen concentrations, and degree of platelet adhesiveness were all higher in those with proteinuria than in those without. Patients with "complicated" jvf-.b.li-dp.ndu-, di. disease-that is, with either retinopathy or proteinuria or bothhad significantly higher values for factors V and VII, fibrinogen, and antithrombin III than those with "uncomplicated" disease. Multiple regression analysis showed that the associations of antithrombin III with retinopathy and of factor VII, fibrinogen, and platelet adhesiveness with proteinuria occurred independently of age, sex, duration and type of diabetes, smoking, and blood pressure. There was no difference in any haemostatic variable between diabetics with and without clinical or electrocardiographic evidence of ischaemic heart disease.
Results
antithrombin III (which may also indicate a protective response), fibrinogen, and platelet adhesiveness suggest a role for these variables in microvascular disease but were not entirely consistent in the retinopathy and proteinuria groups. In contrast to Almer et al,2' we did not find impaired fibrinolytic activity in diabetics with retinopathy compared with those without.
In summary the results of this cross-sectional study confirm that diabetics have abnormalities of coagulation factors, fibrino- 
Discussion
In comparing the diabetics with non-diabetics (tables II and IVm) the findings for factors VII and X, fibrinogen, fibrinolytic activity, and platelet adhesiveness were all compatible with the hypothesis that disordered haemostatic function favouring an increased thrombotic tendency is associated with the specific vascular complications of diabetes. Our results, in large groups of non-diabetic and diabetic subjects, broadly agreed with those of other workers.5 61314 The lower platelet count in the diabetics may have been due to an increased platelet turnover as part of a generally increased level of platelet activity.15 Even allowing for the possibility that recent food intake lowers platelet adhesiveness to the extent suggested by the NPHS data, the difference between the non-diabetics and diabetics was substantial, particularly in men (table II) .
Some groups of diabetics have increased sensitivity to plateletaggregating agents,16 which may be associated with increased platelet prostaglandin synthesis or an interaction with plasma factors, such as the von Willebrand factor. '7 Our results for factor VIII were inconsistent and do not confirm the reported difference between non-diabetics and diabetics.4 6
The poorer fibrinolytic activity in the diabetics was mainly attributable to the NIDD group. This impaired activity was probably not due to oral antidiabetic agents, since Bogie et al"8 found no significant change in fibrinolytic activity over one year in patients with NIDD allocated at random to treatment with glibenclamide, phenformin, both drugs, or diet alone.
At first sight the direction of difference in antithrombin III values between the non-diabetics and diabetics seems paradoxical; diabetics might be expected to have lower values in view of the increased risk of thromboembolic disease in those with congenital antithrombin III deficiency. 19 Patients without congenital deficiency who have had clinical episodes of ischaemic heart disease or are at risk of developing the disease, however, have high antithrombin III values,20 possibly as a protective response. A similar explanation may apply in diabetes.
Our results also suggest that an increased thrombotic tendency may be related to the onset of microvascular disease in diabetes, although as with the findings already -discussed prospective data are needed to distinguish cause and consequence. Mean factor VII values were higher in diabetics with retinopathy and proteinuria than in those without (table V). The findings for lytic activity, and platelet function. This "increased thrombotic tendency" may play a part in the vascular complications of diabetes. Studies are needed to show whether correction of these haemostatic abnormalities by therapeutic intervention or improved diabetic control or both will lower the incidence of large-vessel and small-vessel disease in diabetes.
